Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Methadone maintenance treatment reduces heroin injection in New South Wales prisons.

Dolan KA, Wodak AD, Hall WD.

Drug Alcohol Rev. 1998 Jun;17(2):153-8.

PMID:
16203480
2.

Drug use and injection risk-taking among prison methadone maintenance patients.

Darke S, Kaye S, Finlay-Jones R.

Addiction. 1998 Aug;93(8):1169-75.

PMID:
9813898
3.

Evaluation of a cognitive-behavioural intervention for HIV prevention among injecting drug users.

Baker A, Heather N, Wodak A, Dixon J, Holt P.

AIDS. 1993 Feb;7(2):247-56.

PMID:
8466688
4.

Value for money in drug treatment: economic evaluation of prison methadone.

Warren E, Viney R, Shearer J, Shanahan M, Wodak A, Dolan K.

Drug Alcohol Depend. 2006 Sep 15;84(2):160-6. Epub 2006 Feb 17.

PMID:
16487668
5.

[Evaluation of the prevalence of HIV infection in prison inmates at the time of their imprisonment during the period 1991-1995].

Martín Sánchez V, Caylá Buqueras JA, González Morís ML, Herrero Alonso LE, Vicente Pérez R.

Rev Esp Salud Publica. 1997 May-Jun;71(3):269-80. Review. Spanish.

6.

A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.

Dolan KA, Shearer J, MacDonald M, Mattick RP, Hall W, Wodak AD.

Drug Alcohol Depend. 2003 Oct 24;72(1):59-65.

PMID:
14563543
7.

HIV transmission in a prison system in an Australian State.

Dolan KA, Wodak A.

Med J Aust. 1999 Jul 5;171(1):14-7.

PMID:
10451665
8.

Methadone maintenance treatment in prisons: The New South Wales Experience.

Hall W, Ward J, Mattick R.

Drug Alcohol Rev. 1993;12(2):193-203.

PMID:
16818329
9.

The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.

Butler T, Boonwaat L, Hailstone S, Falconer T, Lems P, Ginley T, Read V, Smith N, Levy M, Dore G, Kaldor J.

Aust N Z J Public Health. 2007 Feb;31(1):44-50.

PMID:
17333608
10.

Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.

Heimer R, Catania H, Newman RG, Zambrano J, Brunet A, Ortiz AM.

Drug Alcohol Depend. 2006 Jun 28;83(2):122-9. Epub 2005 Dec 5.

PMID:
16332415
11.

'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.

Bloor M, McIntosh J, McKeganey N, Robertson M.

Public Health. 2008 Oct;122(10):1013-9. doi: 10.1016/j.puhe.2008.01.007. Epub 2008 May 19.

PMID:
18490036
12.

The impact of substitution treatment in prisons--a literature review.

Stallwitz A, Stöver H.

Int J Drug Policy. 2007 Dec;18(6):464-74. Epub 2007 Jan 5. Review.

PMID:
18061872
13.

Mortality associated with New South Wales methadone programs in 1994: lives lost and saved.

Caplehorn JR, Drummer OH.

Med J Aust. 1999 Feb 1;170(3):104-9.

PMID:
10065120
14.

Drug use and HIV/AIDS in China.

Liu Z, Lian Z, Zhao C.

Drug Alcohol Rev. 2006 Mar;25(2):173-5. Review.

PMID:
16627308
15.

Attitudes and beliefs towards methadone maintenance treatment among Australian prison health staff.

Gjersing LR, Butler T, Caplehorn JR, Belcher JM, Matthews R.

Drug Alcohol Rev. 2007 Sep;26(5):501-8.

PMID:
17701513
16.

High prevalence of HCV in a cohort of injectors on methadone substitution treatment.

Lee KC, Lim WW, Lee SS.

J Clin Virol. 2008 Apr;41(4):297-300. doi: 10.1016/j.jcv.2007.09.013. Epub 2008 Jan 10.

PMID:
18191614
17.

Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.

Winstock AR, Lea T, Sheridan J.

Int J Drug Policy. 2008 Dec;19(6):450-8. doi: 10.1016/j.drugpo.2007.03.002. Epub 2008 Mar 21.

PMID:
18359216
18.

A bleach program for inmates in NSW: an HIV prevention strategy.

Dolan KA, Wodak AD, Hall WD.

Aust N Z J Public Health. 1998 Dec;22(7):838-40.

PMID:
9889456
19.

Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.

Suntharasamai P, Martin M, Vanichseni S, van Griensven F, Mock PA, Pitisuttithum P, Tappero JW, Sangkum U, Kitayaporn D, Gurwith M, Choopanya K; Bangkok Vaccine Evaluation Group.

Addiction. 2009 Feb;104(2):235-42. doi: 10.1111/j.1360-0443.2008.02436.x.

PMID:
19149819
20.

Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.

Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K.

J Psychiatr Pract. 2009 May;15(3):227-34. doi: 10.1097/01.pra.0000351884.83377.e2.

PMID:
19461397

Supplemental Content

Support Center